https://www.live-feeds.com/feed/new-oral-glp-1-drug-delivers-up-to-12-weight-loss-in-36-weeksContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/new-oral-glp-1-drug-delivers-up-to-12-weight-loss-in-36-weekshttps://www.live-feeds.com/feed/new-oral-glp-1-drug-delivers-up-to-12-weight-loss-in-36-weeks#u20765Thu, 02 Jul 2026 00:56:43 +0000A new oral GLP-1 medication has demonstrated weight loss of up to 12% over 36 weeks. Meanwhile, Medicare is launching a pilot program to expand access to drugs like Zepbound and Wegovy. This initiative aims to make weight loss medications more affordable for some beneficiaries.What's confirmed:A new oral GLP-1 drug delivers up to 12% weight loss in 36 weeks.A Medicare pilot began Wednesday to broaden access to medications including Zepbound and Wegovy.Still unconfirmed:The Bridge program may enable affordable access for some Medicare beneficiaries.Unique risks exist for people over 65 using GL